Share
Market Research Report

MONOCLONAL ANTIBODIES FOR CANCER AND NON-CANCER DIAGNOSTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Antibody TypeMurine Antibodies · Rabbit Antibodies · Chimeric Antibodies · Humanized Antibodies · Fully Human Antibodies · Recombinant Antibodies · and Others
  • By Usage TechniquesEnzyme-Linked Immunosorbent Assay (ELISA) · Chemiluminescent Immunoassay (CLIA) · Western Blot (WB) · Immunohistochemistry (IHC) · Immunoprecipitation (IP) · Immunofluorescence (IF) · Lateral Flow Assay · and Others
  • By ApplicationCancer · Obstetrics · Dengue · Chikungunya · Helicobacter pylori · Syphilis · HIV (Human immunodeficiency virus) · and Others
  • By End UserClinical and Diagnostic Laboratories · Hospitals · Biopharmaceutical Companies · Research Institutions · and Others
  • By Distribution ChannelOffline and Online
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In26 Jun 2026
  • Report CodeCMI9693
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Antibody Type
      • Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Usage Techniques
      • Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Application
      • Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By End User
      • Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Distribution Channel
      • Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Industry Trends
  4. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Antibody Type, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Murine Antibodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Rabbit Antibodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Chimeric Antibodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Humanized Antibodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Fully Human Antibodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Recombinant Antibodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  5. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Usage Techniques, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Chemiluminescent Immunoassay (CLIA)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Western Blot (WB)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Immunohistochemistry (IHC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Immunoprecipitation (IP)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Immunofluorescence (IF)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Lateral Flow Assay
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  6. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Application, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Obstetrics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Dengue
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Chikungunya
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Helicobacter pylori
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Syphilis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • HIV (Human immunodeficiency virus)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  7. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By End User, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Clinical and Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Biopharmaceutical Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Research Institutions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  8. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Distribution Channel, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Offline
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Online
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  9. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Region, 2021 - 2033, Value (USD Mn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
        • South Africa
        • North Africa
        • Central Africa
  10. Competitive Landscape

    • F. Hoffmann-La Roche Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Agilent Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Danaher Corporation
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bio-Rad Laboratories, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Abbott Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • QIAGEN N.V.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck KGaA
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Abcam plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sino Biological, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  11. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  12. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on ‘Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market' - Global forecast to 2033